Ipilimumab +Nivolumab + Cryotherapy in Metastatic or Locally Advanced Soft Tissue Sarcoma
Status:
Active, not recruiting
Trial end date:
2025-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this Phase II study is to
1. find out if the study drugs (ipilimumab plus nivolumab) in combination with cryotherapy
will help participants with metastatic or locally advanced soft tissue sarcoma;.
2. find out how safe are ipilimumab plus nivolumab given in combination with cryotherapy,
and what side effects may be related to treatment.
3. find out how do the study drugs in combination with cryotherapy work in soft tissue
sarcoma.